missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. LIM Kinase 1 Antibody, Novus Biologicals™
  7. 30228855

LIM Kinase 1 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP3-35690-100ul

 View more versions of this product

Product Code. 30228855

  • £417.00 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

LIM Kinase 1 Polyclonal antibody specifically detects LIM Kinase 1 in Human,Mouse,Rat samples. It is validated for ELISA,Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

LIM Kinase 1
Polyclonal
Western Blot 1:500 - 1:2000, ELISA
EC 2.7.11.1, LIM domain kinase 1, LIM motif-containing protein kinase, LIMKLIMK-1
Recombinant fusion protein containing a sequence corresponding to amino acids 510-647 of LIM Kinase 1 (NP_002305.1).,, Sequence:, VGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDRGFWETYRRGESGLPAHPEVPD
100 μL
Breast Cancer, Cancer, Phospho Specific, Protein Kinase
3984
Store at -20°C. Avoid freeze-thaw cycles.
IgG
ELISA, Western Blot
Unconjugated
PBS (pH 7.3), 50% glycerol
Rabbit
Affinity purified
RUO
Primary
Human, Mouse, Rat
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.